Incorvaia L, Bazan Russo T, Gristina V, Perez A, Brando C, Mujacic C
NPJ Precis Oncol. 2024; 8(1):190.
PMID: 39237751
PMC: 11377838.
DOI: 10.1038/s41698-024-00672-0.
Scheuren M, Mohner J, Muller M, Zischler H
Front Genet. 2024; 15:1423674.
PMID: 39040993
PMC: 11260735.
DOI: 10.3389/fgene.2024.1423674.
Fujita H, Wakiya T, Tatara Y, Ishido K, Sakamoto Y, Kimura N
Sci Rep. 2024; 14(1):16557.
PMID: 39019993
PMC: 11254928.
DOI: 10.1038/s41598-024-66004-1.
Manaka Y, Kusumoto-Matsuo R, Matsuno Y, Asai H, Yoshioka K
Heliyon. 2024; 10(6):e28044.
PMID: 38545229
PMC: 10965518.
DOI: 10.1016/j.heliyon.2024.e28044.
Yamashita S, Miyazawa T, Higuchi O, Kinoshita M, Miyazawa T
Molecules. 2023; 28(17).
PMID: 37687157
PMC: 10488995.
DOI: 10.3390/molecules28176328.
TUG1-mediated R-loop resolution at microsatellite loci as a prerequisite for cancer cell proliferation.
Suzuki M, Iijima K, Ogami K, Shinjo K, Murofushi Y, Xie J
Nat Commun. 2023; 14(1):4521.
PMID: 37607907
PMC: 10444773.
DOI: 10.1038/s41467-023-40243-8.
PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma.
Song F, Wang C, Mao J, Wang T, Liang X, Hu C
Front Immunol. 2023; 14:1197152.
PMID: 37398672
PMC: 10311484.
DOI: 10.3389/fimmu.2023.1197152.
Learning and Investigation of the Role of Angiotensin-Converting Enzyme in Radiotherapy for Nasopharyngeal Carcinoma.
Ding Y, Xiu H, Zhang Y, Ke M, Lin L, Yan H
Biomedicines. 2023; 11(6).
PMID: 37371679
PMC: 10295367.
DOI: 10.3390/biomedicines11061581.
CLDN5 identified as a biomarker for metastasis and immune infiltration in gastric cancer via pan-cancer analysis.
Han L, Cui D, Huang B, Yang Q, Huang T, Lin G
Aging (Albany NY). 2023; 15(11):5032-5051.
PMID: 37286335
PMC: 10292893.
DOI: 10.18632/aging.204776.
Biomaterial-enabled therapeutic modulation of cGAS-STING signaling for enhancing antitumor immunity.
Liu Y, Fei Y, Wang X, Yang B, Li M, Luo Z
Mol Ther. 2023; 31(7):1938-1959.
PMID: 37002605
PMC: 10362396.
DOI: 10.1016/j.ymthe.2023.03.026.
Microsatellite instability-related prognostic risk score (MSI-pRS) defines a subset of lung squamous cell carcinoma (LUSC) patients with genomic instability and poor clinical outcome.
Hu Z, Liu Z, Zheng J, Peng Y, Lu X, Li J
Front Genet. 2023; 14:1061002.
PMID: 36873930
PMC: 9981642.
DOI: 10.3389/fgene.2023.1061002.
Genome destabilization-associated phenotypes arising as a consequence of therapeutic treatment are suppressed by Olaparib.
Suzuki M, Fujimori H, Wakatsuki K, Manaka Y, Asai H, Hyodo M
PLoS One. 2023; 18(1):e0281168.
PMID: 36706121
PMC: 9882903.
DOI: 10.1371/journal.pone.0281168.
Echoed induction of nucleotide variants and chromosomal structural variants in cancer cells.
Matsuno Y, Kusumoto-Matsuo R, Manaka Y, Asai H, Yoshioka K
Sci Rep. 2022; 12(1):20964.
PMID: 36470958
PMC: 9723101.
DOI: 10.1038/s41598-022-25479-6.
Mechanism-based design of agents that selectively target drug-resistant glioma.
Lin K, Gueble S, Sundaram R, Huseman E, Bindra R, Herzon S
Science. 2022; 377(6605):502-511.
PMID: 35901163
PMC: 9502022.
DOI: 10.1126/science.abn7570.
KMT2C-deficient tumors have elevated APOBEC mutagenesis and genomic instability in multiple cancers.
Hu X, Biswas A, De S
NAR Cancer. 2022; 4(3):zcac023.
PMID: 35898555
PMC: 9310081.
DOI: 10.1093/narcan/zcac023.
Homologous Recombination Related Signatures Predict Prognosis and Immunotherapy Response in Metastatic Urothelial Carcinoma.
Li P, Chen C, Li J, Yang L, Wang Y, Dong Z
Front Genet. 2022; 13:875128.
PMID: 35559013
PMC: 9086193.
DOI: 10.3389/fgene.2022.875128.
SERPINH1 is a Potential Prognostic Biomarker and Correlated With Immune Infiltration: A Pan-Cancer Analysis.
Wang Y, Gu W, Wen W, Zhang X
Front Genet. 2022; 12:756094.
PMID: 35058967
PMC: 8764125.
DOI: 10.3389/fgene.2021.756094.
Genomic Instability and Cancer Risk Associated with Erroneous DNA Repair.
Yoshioka K, Kusumoto-Matsuo R, Matsuno Y, Ishiai M
Int J Mol Sci. 2021; 22(22).
PMID: 34830134
PMC: 8625880.
DOI: 10.3390/ijms222212254.
Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer.
Tomasini P, Guecheva T, Leguisamo N, Pericart S, Brunac A, Hoffmann J
Cancers (Basel). 2021; 13(13).
PMID: 34201502
PMC: 8268241.
DOI: 10.3390/cancers13133130.
Replication-stress-associated DSBs induced by ionizing radiation risk genomic destabilization and associated clonal evolution.
Matsuno Y, Hyodo M, Suzuki M, Tanaka Y, Horikoshi Y, Murakami Y
iScience. 2021; 24(4):102313.
PMID: 33870130
PMC: 8042347.
DOI: 10.1016/j.isci.2021.102313.